Agfa HealthCare to show unique web-enabled cardiovascular information system

AGFAAt the occasion of the World Congress of Cardiology in Barcelona, from September 2 until 6, Agfa HealthCare will demonstrate its leading cardiology solution: Agfa Heartlab Cardiovascular. The event also marks the European debut of Heartlab Congenital, the world's most comprehensive and flexible reporting and analysis tool for congenital echocardiography reporting.

Consolidating information from multiple cardiology subspecialties, Agfa Heartlab Cardiovascular improves departmental workflow, enables faster and more accurate diagnosis and creates a comprehensive digital cardiac record. More than twenty facilities on the world market have recently placed orders for Agfa's vendor neutral solution that connects all modality equipment. "Hospitals and clinics across Europe, Asia Pacific and the Middle East have entered into a contract with Agfa HealthCare to adopt the Heartlab Cardio suite, adding significantly to our global presence," said Reid Losee, Agfa's Global Cardiovascular Business Director. "The world market has recognized our clinical and technical expertise in the area of cardiology," she added.

Heart defects are among the most common birth defects and are the leading cause of birth-defect related deaths, according to the American Heart Association (AHA). Advances in diagnosis and surgical treatment have led to dramatic increases in survival for children with serious heart defects, the association has stated. As a result there is a growing population of adults with congenital heart disease. "We're excited to introduce our congenital product to the European market," said Dr. William Drake, Agfa's Congenital Heart Product Manager. "A large population of children and adults with congenital heart disease will benefit from these dynamic analysis and diagnostic tools."

Gayle J. Wheeler
MarCom Manager BU Cardiovascular
One Crosswind Road
RI 02891 Westerly, Rhode Island (USA)
tel:+1 (0)401 604 22 66
fax:+1 (0)401 596 85 62
This email address is being protected from spambots. You need JavaScript enabled to view it.

Johan Jacobs
Corporate Press Relations Manager
Septestraat 27
2640 Mortsel - Belgium
tel:+32 (0)3 444 80 15
fax:+32 (0)3 444 50 05
This email address is being protected from spambots. You need JavaScript enabled to view it.

Werner Vandevelde
Global MarCom Leader IT solutions HealthCare
Septestraat 27
2640 Mortsel - Belgium
tel:+32 (0)3 444 80 04
fax:+32 (0)3 444 72 85
This email address is being protected from spambots. You need JavaScript enabled to view it.

Most Popular Now

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

AI Model Forecasts Disease Risk Decades …

Imagine a future where your medical history could help predict what health conditions you might face in the next two decades. Researchers have developed a generative AI model that uses...

AI Model Indicates Four out of Ten Breas…

A project at Lund University in Sweden has trained an AI model to identify breast cancer patients who could be spared from axillary surgery. The model analyses previously unutilised information...

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...